Breast cancer, Secondary cancers
Results
Phase 3
This trial compared olaparib with chemotherapy for breast cancer that has spread. It was for people who have breast cancer and a change to the BRCA1 or BRCA2 gene.
The trial was open for people to join between 2014 and 2015. The research team reported these results in 2020.
Recruitment start: 19 May 2014
Recruitment end: 9 October 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Anne Armstrong
AstraZeneca
NIHR Clinical Research Network: Cancer
Last reviewed: 15 Jun 2022
CRUK internal database number: 12070
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
